Lates News

date
19/08/2025
Hong Kong stocks' biopharmaceutical concept continued to decline in the afternoon, with Gali Pharmaceutical-B falling more than 15%, Peg Bio-B falling more than 7%, Jiangsu Hengrui Medicine falling more than 6%, and BeiGene falling more than 3%.